Dyego Mondego Moraes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dyego Mondego Moraes has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Augusto Gomes Alves
Universidade Federal do Pernambuco
4 shared publications - João Victor Carvalho da Paz
Universidade Ceuma
4 shared publications - Amanda de Morais Melo
Universidade Ceuma
3 shared publications - Beatriz da Cruz Alves
Florida Atlantic University
3 shared publications - Camila Melo de Freitas
Faculdade Pitágoras de Medicina
3 shared publications - Lucas Frota Beckman
Universidade Ceuma
3 shared publications
Latest Publications
- Open Access
- 14 May 2022
- Published by e-Academica in E-Acadêmica
- Vol. 3 (2) , e7832103
Estenose congênita do esôfago: relato de caso
Introduction: Congenital esophageal stricture (CES) is a rare pathology characterized by an intrinsic narrowing of the esophageal lumen due to a structural wall abnormality. The CES can be classified etiologically into 3 categories: tracheobronchial remnants (RTB), fibromuscular hypertrophy (MFT) and diaphragmatic membrane (MD). Dysphagia is the initial clinical manifestation, which begins with the introduction of solid foods into the infant diet. Other common symptoms include vomiting, low growth, and recurrent lower respiratory infections. Esophagography is the most common complementary exam for the diagnosis of CES. Description of the case: A.G.B.F., male, black, 2 years old, with diagnostic hypothesis closed at 17 months when was taken to medical attention at the Hospital da Criança with complaints of gagging after eating, difficulty in eating solid foods, recurrent episodes of emesis and a severe low nutrition. He was referred to the Juvêncio Mattos Children's Hospital to perform a gastrostomy without antireflux procedure. Ten months later, the patient was admitted to the Maternal and Child Hospital Complex for esophagoplasty and esophagogastroanastomosis, evolving to hospital. Conclusion: Finally, it is concluded that therapeutic management should be carried out as soon as possible in order to avoid low nutrition and delayed growth.
- 14 May 2022
- Published by e-Academica in E-Acadêmica
- Vol. 3 (2) , e7832103
Open AccessEstenose congênita do esôfago: relato de caso
Introduction: Congenital esophageal stricture (CES) is a rare pathology characterized by an intrinsic narrowing of the esophageal lumen due to a structural wall abnormality. The CES can be classified etiologically into 3 categories: tracheobronchial remnants (RTB), fibromuscular hypertrophy (MFT) and diaphragmatic membrane (MD). Dysphagia is the initial clinical manifestation, which begins with the introduction of solid foods into the infant diet. Other common symptoms include vomiting, low growth, and recurrent lower respiratory infections. Esophagography is the most common complementary exam for the diagnosis of CES. Description of the case: A.G.B.F., male, black, 2 years old, with diagnostic hypothesis closed at 17 months when was taken to medical attention at the Hospital da Criança with complaints of gagging after eating, difficulty in eating solid foods, recurrent episodes of emesis and a severe low nutrition. He was referred to the Juvêncio Mattos Children's Hospital to perform a gastrostomy without antireflux procedure. Ten months later, the patient was admitted to the Maternal and Child Hospital Complex for esophagoplasty and esophagogastroanastomosis, evolving to hospital. Conclusion: Finally, it is concluded that therapeutic management should be carried out as soon as possible in order to avoid low nutrition and delayed growth.
- Open Access
- 14 May 2022
- Published by e-Academica in E-Acadêmica
- Vol. 3 (2) , e7232204
Carcinoma Adrenocortical e a relação genética: uma revisão de literatura
Introduction: Adrenal tumors are very common, affecting 3% to 10% of the human population, and most are small non-functional benign adrenocortical adenomas (ACA). ACC, in contrast, is a very rare disease. Methodology: This is a systematic literature review of a quantitative type using the following descriptors: Adrenocortical Carcinoma, Adrenal Cortex, Endocrinology, Genetic Predisposition to Disease and Paraneoplastic Endocrine Syndromes. Result: Patients with ACC rarely present with classic tumor symptoms such as cachexia or night sweats. Paraneoplastic syndromes are uncommon. However, tumor-associated hypoglycemia is a well-described phenomenon, historically called Anderson syndrome, which can be attributed to IGF-2-mediated hypoglycemia. Discussion: Proper preoperative assessment and operative planning by a surgeon experienced in the resection of malignant adrenal tumors are of utmost importance to ensure the optimal outcome. Consideration of the surgical anatomy, the potential complications of the surgical intervention, the expected results including recovery time and the various intervention options are important with regard to the beneficial application of surgical management strategies for patients with ACC. Conclusion: While it is true that it is the only drug approved for the treatment of ACC, it also has limited efficacy and may interfere with trials with new therapeutic agents. However, we will await further discussions on the scientific and ethical perspectives of this issue.
- 14 May 2022
- Published by e-Academica in E-Acadêmica
- Vol. 3 (2) , e7232204
Open AccessCarcinoma Adrenocortical e a relação genética: uma revisão de literatura
Introduction: Adrenal tumors are very common, affecting 3% to 10% of the human population, and most are small non-functional benign adrenocortical adenomas (ACA). ACC, in contrast, is a very rare disease. Methodology: This is a systematic literature review of a quantitative type using the following descriptors: Adrenocortical Carcinoma, Adrenal Cortex, Endocrinology, Genetic Predisposition to Disease and Paraneoplastic Endocrine Syndromes. Result: Patients with ACC rarely present with classic tumor symptoms such as cachexia or night sweats. Paraneoplastic syndromes are uncommon. However, tumor-associated hypoglycemia is a well-described phenomenon, historically called Anderson syndrome, which can be attributed to IGF-2-mediated hypoglycemia. Discussion: Proper preoperative assessment and operative planning by a surgeon experienced in the resection of malignant adrenal tumors are of utmost importance to ensure the optimal outcome. Consideration of the surgical anatomy, the potential complications of the surgical intervention, the expected results including recovery time and the various intervention options are important with regard to the beneficial application of surgical management strategies for patients with ACC. Conclusion: While it is true that it is the only drug approved for the treatment of ACC, it also has limited efficacy and may interfere with trials with new therapeutic agents. However, we will await further discussions on the scientific and ethical perspectives of this issue.
- Open Access
- 14 May 2022
- Published by e-Academica in E-Acadêmica
- Vol. 3 (2) , e4832203
Apoplexia de tumor hipofisário: uma revisão de literatura
Introduction: Pituitary apoplexy is a potentially fatal disorder due to acute ischemic infarction or hemorrhage of the pituitary gland. The main clinical features of this syndrome are headache, nausea, vomiting, visual impairment, altered mental status and even coma. Methodology: This is a systematic literature review of the quantitative type using the following Keywords: Adeno-Pituitary; Pituitary Apoplexy; Pituitary Neoplasms; Review of Reported Cases. Result: As the primary event involves the adenoma, the syndrome should be termed pituitary tumor apoplexy and not pituitary apoplexy. Although pituitary apoplexy occurs within pituitary adenomas, it can also occur in non-adenomatous or even normal pituitary, especially during pregnancy. Discussion: Although the terminology "subclinical pituitary apoplexy" is widely used to describe anatomopathological evidence of asymptomatic pituitary ischemia or hemorrhage, it is significant to note that pituitary apoplexy is a clinical syndrome and not an anatomopathological definition. Conclusion: although pituitary apoplexy is an uncommon complication of pituitary tumors, it must be recognized as a neuroendocrinological and neurosurgical emergency that requires immediate diagnosis and treatment, individualizing each individual to direct to conservative or more invasive therapies.
- 14 May 2022
- Published by e-Academica in E-Acadêmica
- Vol. 3 (2) , e4832203
Open AccessApoplexia de tumor hipofisário: uma revisão de literatura
Introduction: Pituitary apoplexy is a potentially fatal disorder due to acute ischemic infarction or hemorrhage of the pituitary gland. The main clinical features of this syndrome are headache, nausea, vomiting, visual impairment, altered mental status and even coma. Methodology: This is a systematic literature review of the quantitative type using the following Keywords: Adeno-Pituitary; Pituitary Apoplexy; Pituitary Neoplasms; Review of Reported Cases. Result: As the primary event involves the adenoma, the syndrome should be termed pituitary tumor apoplexy and not pituitary apoplexy. Although pituitary apoplexy occurs within pituitary adenomas, it can also occur in non-adenomatous or even normal pituitary, especially during pregnancy. Discussion: Although the terminology "subclinical pituitary apoplexy" is widely used to describe anatomopathological evidence of asymptomatic pituitary ischemia or hemorrhage, it is significant to note that pituitary apoplexy is a clinical syndrome and not an anatomopathological definition. Conclusion: although pituitary apoplexy is an uncommon complication of pituitary tumors, it must be recognized as a neuroendocrinological and neurosurgical emergency that requires immediate diagnosis and treatment, individualizing each individual to direct to conservative or more invasive therapies.
- Open Access
- 27 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (5)
O desafio presente no diagnóstico e no tratamento do câncer de bexiga
Introdução: O câncer de bexiga é a nona neoplasia mais comum em todo o mundo. É uma doença diversificada com resultados diferentes relacionados à sua biologia básica subjacente, capacidade de resposta à terapia e fatores relacionados ao hospedeiro. Fatores de risco estabelecidos para câncer de bexiga incluem sexo masculino, idade avançada, raça branca, exposição ocupacional a certos produtos químicos, radiação pélvica, uso de medicamentos como ciclofosfamida, infecção/irritação crônica da bexiga, história pessoal ou familiar de câncer de bexiga e tabagismo. Método: A plataforma de busca nos seguintes sites: SciELO, Google acadêmico, International Brazilian Journal of Urology, The Journal of Urology, PUBLAB e o PUBMED. Resultado e discursão: Como resultado, o espectro da doença varia de uma entidade relativamente benigna que é mais incômoda do que qualquer outra coisa a uma variante letal com grande potencial metastático. Por essas razões, a detecção precoce, marcadores de evolução da doença e boas terapias cirúrgicas e médicas são primordiais para impactar sua história natural. Ao longo dos últimos 30 anos, os avanços na técnica endoscópica e cirúrgica, juntamente com as descobertas com imuno e quimioterapia, resultaram em melhorias substanciais no atendimento de pacientes com esta doença. Conclusão: Nesta revisão de literatura, destacamos descobertas recentes que estabelecem um novo e emergente padrão de atendimento para o tratamento e diagnostico de pacientes com câncer de bexiga. Como as taxas de recorrência e mortalidade do câncer de bexiga são altas, são necessárias pesquisas para encontrar biomarcadores adequados para detecção precoce, avaliação do prognóstico e vigilância das respostas aos medicamentos.
- 27 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (5)
Open AccessO desafio presente no diagnóstico e no tratamento do câncer de bexiga
Introdução: O câncer de bexiga é a nona neoplasia mais comum em todo o mundo. É uma doença diversificada com resultados diferentes relacionados à sua biologia básica subjacente, capacidade de resposta à terapia e fatores relacionados ao hospedeiro. Fatores de risco estabelecidos para câncer de bexiga incluem sexo masculino, idade avançada, raça branca, exposição ocupacional a certos produtos químicos, radiação pélvica, uso de medicamentos como ciclofosfamida, infecção/irritação crônica da bexiga, história pessoal ou familiar de câncer de bexiga e tabagismo. Método: A plataforma de busca nos seguintes sites: SciELO, Google acadêmico, International Brazilian Journal of Urology, The Journal of Urology, PUBLAB e o PUBMED. Resultado e discursão: Como resultado, o espectro da doença varia de uma entidade relativamente benigna que é mais incômoda do que qualquer outra coisa a uma variante letal com grande potencial metastático. Por essas razões, a detecção precoce, marcadores de evolução da doença e boas terapias cirúrgicas e médicas são primordiais para impactar sua história natural. Ao longo dos últimos 30 anos, os avanços na técnica endoscópica e cirúrgica, juntamente com as descobertas com imuno e quimioterapia, resultaram em melhorias substanciais no atendimento de pacientes com esta doença. Conclusão: Nesta revisão de literatura, destacamos descobertas recentes que estabelecem um novo e emergente padrão de atendimento para o tratamento e diagnostico de pacientes com câncer de bexiga. Como as taxas de recorrência e mortalidade do câncer de bexiga são altas, são necessárias pesquisas para encontrar biomarcadores adequados para detecção precoce, avaliação do prognóstico e vigilância das respostas aos medicamentos.